AMEE ROZANC: Open Payments
NPI 1255516134 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$53,144 in 224 payments from 19 companies in 2025. Trend: 2023 $13,395 · 2024 $31,732 · 2025 $53,144
Speaker / faculty: $37,538Travel & lodging: $10,241Food & beverage: $4,115Consulting: $1,250
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 88 | $46,593 |
| E.R. Squibb & Sons, L.L.C. | 15 | $4,230 |
| UCB, Inc. | 17 | $472 |
| Novartis Pharmaceuticals Corporation | 10 | $397 |
| Galderma Laboratories, L.P. | 16 | $256 |
| LEO Pharma Inc. | 10 | $253 |
| Organon LLC | 15 | $230 |
| ABBVIE INC. | 23 | $212 |
| Amgen Inc. | 13 | $158 |
| Almirall LLC | 3 | $75 |
Products named: TREMFYA, Sotyktu, Bimzelx, ADBRY, VTAMA, NEMLUVIO, OTEZLA, RINVOQ.
Industry payments across MO — which companies pay providers there.
